Abstract
Background: Dystroglycanopathies are a clinically and genetically heterogeneous group of muscular dystrophies caused by impaired glycosylation of α ‐dystroglycan, with variants in multiple genes, including CRPPA , which is associated with a broad spectrum ranging from congenital muscular dystrophy to limb‐girdle muscular dystrophy. Method: The proband underwent whole exome sequencing, while Sanger sequencing was used for segregation analysis and oligonucleotide array‐CGH was performed to confirm the copy number variant. Results: We report two siblings harboring an identical novel compound heterozygous CRPPA genotype, comprising a novel c.267G>C missense variant and a deletion encompassing exons 9–10. Despite sharing the same genotype, the siblings showed marked phenotypic variability. The female sibling developed childhood‐onset disease with proximal weakness involving both the upper and lower limbs, whereas the male sibling presented with late‐onset disease and weakness confined to the proximal lower limbs, accompanied by markedly discordant serum creatine kinase levels (1193 vs. 460 U/L). Conclusion: These findings expand the mutational and clinical spectrum of CRPPA‐related dystroglycanopathy, highlight marked intrafamilial phenotypic variability, and emphasize the importance of integrated single‐nucleotide and copy number variant analysis in the genetic diagnosis of neuromuscular disorders.